The Saudi Mais Company for Medical Products was able to produce the first N95 masks manufactured in the Kingdom from polypropylene manufactured by (SABIC) in cooperation with the Dimas Nonwoven Fabrics Company, and the product obtained the necessary approvals after meeting the requirements of the Saudi Food and Drug Authority.
Vice Chairman and Chief Executive Officer Yousef bin Abdullah Al-Bunyan affirmed SABIC’s keenness to Supporting the national industry and achieving the goals of the Kingdom’s Vision 2030, to enable local content and strategic industries through its national initiative, We Support, noting that the company is working in an integrated manner with industrial institutions in the Kingdom, to provide innovative and sustainable solutions by developing raw materials that are used in the manufacture of products of high importance to society, and raising their quality and efficiency.
Al-Bunyan added, “The local production of these masks represents an important step in the field of localizing medical products, which contributes to enhancing prevention and raising public health levels, noting that the Nusaned ™ initiative works with a wide base of local entrepreneurs and manufacturers in the field of localizing strategic industries and transferring the technologies necessary for these industries”.
For his part, a team from SABIC visited the factory of Dimas Company and the factory of the Saudi Mais Company for Medical Products. The success of this experiment in embodying the importance of joint cooperation between the private and public sectors to support national products, and to localize industries in the field of personal and health protection equipment.
It is noteworthy that SABIC’s Petrochemicals Strategic Business Unit launched the “Personal Care and Healthcare” unit last September to enhance focus on producing specialized solutions that employ innovation in meeting the needs of customers in this field, and keeping pace with global changes by increasing the petrochemical sector’s contribution to the medical industries. Especially after the new Corona pandemic affected the supply chains of personal protection products, which led to the imposition of restrictions on their exports in many countries.